May 26, 2026 08:03AM

Apr 15, 2026 08:04AM

Mar 11, 2026 07:24AM

Feb 2, 2026 08:03AM

Jan 28, 2026 08:02AM

Jan 22, 2026 08:03AM

Dec 29, 2025 08:02AM 60 Degrees Pharmaceuticals finds Babesia in 24% of chronic fatigue patients

Dec 11, 2025 08:02AM

Nov 21, 2025 08:01AM

Oct 15, 2025 07:14AM

Oct 9, 2025 07:05AM

Oct 2, 2025 09:00AM

Aug 19, 2025 08:54AM

Jul 17, 2025 08:01AM 60 Degrees Pharmaceuticals partners with Tulane to study lyme treatment

Jul 15, 2025 07:02AM

Jul 14, 2025 04:01PM

Jun 4, 2025 08:57AM

Apr 8, 2025 08:31AM

Feb 20, 2025 10:36AM

Feb 11, 2025 12:59PM

Feb 5, 2025 09:23AM 60 Degrees Pharmaceuticals (SXTP) Announces 1.5M Share Offering at $0.715/sh

Jan 29, 2025 08:02AM

Jan 28, 2025 08:01AM

Dec 23, 2024 08:57AM

Dec 11, 2024 08:56AM

Oct 3, 2024 09:02AM

Sep 4, 2024 08:01AM

Aug 28, 2024 02:51PM 60 Degrees Pharmaceuticals (SXTP) Regains Nasdaq Compliance

Aug 14, 2024 11:01AM

Aug 12, 2024 09:12AM

Aug 6, 2024 09:26AM

Jul 25, 2024 09:03AM

Jul 19, 2024 08:29AM

Jul 9, 2024 06:31AM

Jun 11, 2024 07:59AM 60 Degrees Pharmaceuticals (SXTP) Granted FDA Orphan Drug Designation for Tafenoquine

413,555 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All